Community Acquired Pneumonia Clinical Pathway — All Settings
Community Acquired Pneumonia Clinical Pathway — All Settings
Evidence
- Carriage of Mycoplasma pneumoniae in the Upper Respiratory Tract of Symptomatic and Asymptomatic Children: An Observational Study
- The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
- Impact of a Guideline on Management of Children Hospitalized with Community-Acquired Pneumonia
- Narrow vs broad-spectrum antimicrobial therapy for children hospitalized with pneumonia
- Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia
- Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia The SAFER Randomized Clinical Trial
- The SCOUT-CAP Randomized Clinical Trial